Haendel M, Vasilevsky N, Unni D, Bologa C, Harris N, Rehm H, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020;19(2):77–8. https://doi.org/10.1038/d41573-019-00180-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shourick J, Wack M, Jannot AS. Assessing rare diseases prevalence using literature quantification. Orphanet J Rare Dis. 2021;16(1):139. https://doi.org/10.1186/s13023-020-01639-7.

Article  PubMed  Google Scholar 

Richter T, Nestler-Parr S, Babela R, Khan ZM, Tesoro T, Molsen E, et al. Rare disease terminology and definitions—a systematic global review: report of the ISPOR rare disease special interest group. Value Health. 2015;18(6):906–14. https://doi.org/10.1016/j.jval.2015.05.008.

Article  PubMed  Google Scholar 

Tambuyzer E. Rare diseases, orphan drugs and their regulation: questions and misconceptions. Nat Rev Drug Discov. 2010;9(12):921–9. https://doi.org/10.1038/nrd3275.

Article  CAS  PubMed  Google Scholar 

Sharma A, Jacob A, Tandon M, Kumar D. Orphan drug: development trends and strategies. J Pharm Bioallied Sci. 2010;2(4):290–9. https://doi.org/10.4103/0975-7406.72128.

Article  PubMed  PubMed Central  Google Scholar 

Amaryan G, Astvatsatryan V, Gabrielyan E, Panossian A, Panosyan V, Wikman G. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard—a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine. 2003;10(4):271–85. https://doi.org/10.1078/094471103322004767.

Article  CAS  PubMed  Google Scholar 

Song Y, Jia Q, Guan X, Kazuo S, Liu J, Duan W, et al. Herbal medicine for amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Pharmacol. 2022;13:946548. https://doi.org/10.3389/fphar.2022.946548.

Article  PubMed  PubMed Central  Google Scholar 

Chen S, Xu MB, Zhou XL, Rong PQ, Jin TY, Zheng GQ. Chinese herbal medicine for myasthenia gravis: a systematic review and meta-analysis. Front Pharmacol. 2018;9:969. https://doi.org/10.3389/fphar.2018.00969.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu SJ, Wang RT, Yu ZY, Zheng RX, Liang CH, Zheng YY, et al. Chinese herbal medicine for myasthenia gravis: a systematic review and meta-analysis of randomized clinical trials. Integr Med Res. 2022;11(2): 100806. https://doi.org/10.1016/j.imr.2021.100806.

Article  PubMed  Google Scholar 

Guo N, Wu F, Wu M, Wang Y, Lang Q, Lin X, et al. Progress in the design and quality control of placeboe’s for clinical trials of traditional Chinese medicine. J Integr Med. 2022;20(3):204–12. https://doi.org/10.1016/j.joim.2022.02.005.

Article  PubMed  Google Scholar 

Bian ZX, Moher D, Dagenais S, Li YP, Liu L, Wu TX, et al. Improving the quality of randomized controlled trials in Chinese herbal medicine, part II: control group design. Zhong Xi Yi Jie He Xue Bao. 2006;4(2):130–6. https://doi.org/10.3736/jcim20060205.

Article  PubMed  Google Scholar 

Zhang X, Tian R, Zhao C, Tang X, Lu A, Bian Z. Placebo design in WHO-registered trials of Chinese herbal medicine need improvements. BMC Complement Altern Med. 2019;19(1):299. https://doi.org/10.1186/s12906-019-2722-2.

Article  PubMed  PubMed Central  Google Scholar 

Schieppati A, Henter JI, Daina E, Aperia A. Why rare diseases are an important medical and social issue. Lancet. 2008;371(9629):2039–41. https://doi.org/10.1016/s0140-6736(08)60872-7.

Article  PubMed  Google Scholar 

He J, Kang Q, Hu J, Song P, Jin C. China has officially released its first national list of rare diseases. Intractable Rare Dis Res. 2018;7(2):145–7. https://doi.org/10.5582/irdr.2018.01056.

Article  PubMed  PubMed Central  Google Scholar 

Howick J, Webster RK, Rees JL, Turner R, Macdonald H, Price A, et al. TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls. PLoS Med. 2020;17(9):e1003294. https://doi.org/10.1371/journal.pmed.1003294.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Zhang H, Yuan D, et al. Clinical efficacy of compound Huang Qi combined with bromopyzia in the treatment of myasthenia gravis. Chin Arch Tradit Chin Med. 2018;36(04):779–82. https://doi.org/10.13193/j.issn.1673-7717.2018.04.002.

Article  CAS  Google Scholar 

Qiao W, Cui Y, Kong J, Jin D, Wang H, Xie W, et al. To evaluate the efficacy of compound Huangqi granules in the treatment of myasthenia gravis of spleen-kidney deficiency type I and II. Liaoning J Tradit Chin Med. 2018;45(07):1360–3. https://doi.org/10.13192/j.issn.1000-1719.2018.07.005.

Article  CAS  Google Scholar 

Bertoglio JC, Baumgartner M, Palma R, Ciampi E, Carcamo C, Caceres DD, et al. Andrographis paniculata decreases fatigue in patients with relapsing-remitting multiple sclerosis: a 12-month double-blind placebo-controlled pilot study. BMC Neurol. 2016. https://doi.org/10.1186/s12883-016-0595-2.

Article  PubMed  PubMed Central  Google Scholar 

Kim E, Cameron M, Lovera J, Schaben L, Bourdette D, Whitham R. American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study. Mult Scler. 2011;17(12):1523–6. https://doi.org/10.1177/1352458511412062.

Article  CAS  PubMed  Google Scholar 

Naseri M, Ahmadi A, Gharegozli K, Nabavi M, Faghihzadeh S, Ashtarian N, et al. A double blind, placebo-controlled, crossover study on the effect of MS14, an herbal-marine drug, on quality of life in patients with multiple sclerosis. J Med Plants Res. 2009;3(4):271–5.

Google Scholar 

Vaney C, Heinzel-Gutenbrunner M, Jobin P, Tschopp F, Gattlen B, Hagen U, et al. Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study. Mult Scler. 2004;10(4):417–24. https://doi.org/10.1191/1352458504ms1048oa.

Article  CAS  PubMed  Google Scholar 

Deng T, Li R, Li S, Zhang S, Liu X, Yang W, et al. Curative effect of Qiang Ji Jian Li capsule in a randomized, double-blind, self-cross-controled test for myasthenia gravis. J Guangzhou Univ Tradit Chin Med. 1992;9(01):7–10.

Google Scholar 

Qiu G. A single case randomized controlled trial of Qiangji Jianli capsule in the treatment of myasthenia gravis with spleen-stomach qi deficiency. [Master]: GangZhou University of Chinese Medicine; 2022.

Fan M, Zhang Y, Miao Q, Zhang Q, Tao K, et al. Clinical trial of Feitong oral liquid in treating idiopathic pulmonary fibrosis. Tradit Chin Drug Res Clin Pharmacol. 2013;24(03):317–22.

Google Scholar 

Collin C, Davies P, Mutiboko IK, Ratcliffe S, Sativex Spasticity MSSG. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol. 2007;14(3):290–6. https://doi.org/10.1111/j.1468-1331.2006.01639.x.

Article  CAS  PubMed  Google Scholar 

Riva N, Mora G, Sorarù G, Lunetta C, Ferraro OE, Falzone Y, et al. Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2019;18(2):155–64. https://doi.org/10.1016/s1474-4422(18)30406-x.

Article  CAS  PubMed  Google Scholar 

Zhe Z, Liu J, Zhao Z, et al. Clinical study on Modified Xiayuxue Granule combined with prednisone acetate tablets in the treatment of idiopathic pulmonary fibrosis with syndromes of deficiency of qi and yin and obstruction of lung collaterals. Acad J Shanghai Univ Tradit Chin Med. 2020;34(06):9–13. https://doi.org/10.16306/j.1008-861x.2020.06.002.

Article  CAS  Google Scholar 

Wade DT, Makela P, Robson P, House H, Bateman C. Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients. Mult Scler. 2004;10(4):434–41. https://doi.org/10.1191/1352458504ms1082oa.

Article  CAS  PubMed  Google Scholar 

Zhuang Y. Therapeutic effect of integrated traditional Chinese and western medicine on multiple sclerosis. J Pract Tradit Chin Med. 2013;29(06):443–4.

Google Scholar 

Motaghi N, Tajadini H, Shafiei K, Sharififar F, Ansari M, Sharifi H, et al. Lavender improves fatigue symptoms in multiple sclerosis patients: a double-blind, randomized controlled trial. Mult Scler Relat Disord. 2022. https://doi.org/10.1016/j.msard.2022.104000.

Article  PubMed  Google Scholar 

Schröder S, Wang M, Sima D, Schröder J, Zhu X, Zheng X, et al. Slower progression of amyotrophic lateral sclerosis with external application of a Chinese herbal plaster—the randomized, placebo-controlled triple-blinded ALS-CHEPLA trial. Front Neurol. 2022;13:990802. https://doi.org/10.3389/fneur.2022.990802.

Article  PubMed  PubMed Central  Google Scholar 

Rezaeizadeh H, Gharegozli K, Nabavi SM, Shayegannejad V, Ghaffarpoor M, Daneshfard B, et al. Effect of MS14 (R) on physical activity of multiple sclerosis patients: a randomized triple-blind placebo-controlled clinical trial. Mult Scler Relat Disord. 2023. https://doi.org/10.1016/j.msard.2022.104467.

Article  PubMed  Google Scholar 

Adalat M, Khalili M, Ayromlou H, Haririan S, Fazljou SMB, Rezaeizadeh H, et al. Antidepressant effects of a Persian medicine remedy on multiple sclerosis patients: a double-blinded randomized clinical trial. Galen Med J. 2019. https://doi.org/10.31661/gmj.v8i0.1212.

Article  PubMed  PubMed Central  Google Scholar 

Adalat M, Khalili M, Ayromlou H, Haririan S, Rezaeizadeh H, Safari AA, et al. Anti-fatigue and hypnotic effects of a traditional herbal extract on multiple sclerosis patients: a double blind randomized clinical trial. World Fam Med. 2018;16(8):22–31. https://doi.org/10.5742/MEWFM.2018.93484.

Article  Google Scholar 

Guo S, Feng J, Song Y, et al. Effects of Qizhu Kangxian Granules on the pulmonary function and life quality in patients with idiopathic pulmonary fibrosi. China J Tradit Chin Med Pharm. 2019;34(06):2810–4.

CAS  Google Scholar 

Liu Q. Clinical study of Fuzheng Tongluo decoction in the treatment of idiopathic pulmonary interstitial fibrosis syndrome of lung and kidney qi deficiency [Master]: ShangHai University of Chinese Medicine; 2019.